IDO1 and neoplasm: Evidence that direct depletion of kynurenine in vivo using PEGylated kynurenase recapitulates the anti-tumor effects of targeting IDO1, also bolsters the argument in favor of catabolites, and kynurenine in particular, as the mechanism of action through which IDO1 imposes T cell tolerance (28).